First clinical trial of an automated blood drawing and testing device
In the future, robots could take blood samples, benefiting patients and healthcare workers alike.
A Rutgers-led team has created a blood-sampling robot that performed as well or better than people, according to the first human clinical trial of an automated blood drawing and testing device.
The device provides quick results and would allow healthcare professionals to spend more time treating patients in hospitals and other settings.
The results, published in the journal Technology, were comparable to or exceeded clinical standards, with an overall success rate of 87% for the 31 participants whose blood was drawn. For the 25 people whose veins were easy to access, the success rate was 97%.
The device includes an ultrasound image-guided robot that draws blood from veins. A fully integrated device, which includes a module that handles samples and a centrifuge-based blood analyzer, could be used at bedsides and in ambulances, emergency rooms, clinics, doctors’ offices and hospitals.
Venipuncture, which involves inserting a needle into a vein to get a blood sample or perform IV therapy, is the world’s most common clinical procedure, with more than 1.4 billion performed yearly in the United States. But clinicians fail in 27% of patients without visible veins, 40% of patients without palpable veins and 60% of emaciated patients, according to previous studies.
Repeated failures to start an IV line boost the likelihood of phlebitis, thrombosis and infections, and may require targeting large veins in the body or arteries – at much greater cost and risk. As a result, venipuncture is among the leading causes of injury to patients and clinicians. Moreover, a hard time accessing veins can increase procedure time by up to an hour, requires more staff and costs more than $4 billion a year in the United States, according to estimates.
“A device like ours could help clinicians get blood samples quickly, safely and reliably, preventing unnecessary complications and pain in patients from multiple needle insertion attempts,” said lead author Josh Leipheimer, a biomedical engineering doctoral student in the Yarmush lab in the biomedical engineering department in the School of Engineering at Rutgers University–New Brunswick.
In the future, the device could be used in such procedures as IV catheterization, central venous access, dialysis and placing arterial lines. Next steps include refining the device to improve success rates in patients with difficult veins to access. Data from this study will be used to enhance artificial intelligence in the robot to improve its performance.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Mobile Robot Moves Payloads Up to 250 kgon March 18, 2020 at 1:01 pm
The robot is built with sturdier metal skins that can withstand unintended external impacts and more demanding duties. It can also automate the transportation of bulky materials such as transmission ...
- Subscription-Based AI Products Enable Users to Scale with Lower TCO and Shorter Time to Valueon March 18, 2020 at 12:38 pm
The company’s new and simplified subscription model gives users a cost-effective and risk-mitigated path to start realizing significant return on investment through predictive operations. Falkonry ...
- Surgical Operating Microscope Marketon March 11, 2020 at 8:33 am
Surgical Operating Microscope Market Research has offered exhaustive analysis of Manufacturers, Suppliers, Regions, Type and Application, Forecast to 2027. And also provides essential study on the ...
- Advanced robot developed for sampling human bloodon March 1, 2020 at 3:22 am
A new robotic device has been designed to take blood samples and the test results indicate that the machine can undertake a superior job for sampling blood compared with humans. The robot has recently ...
- This blood-drawing robot is more accurate than humanson February 16, 2020 at 10:54 pm
However, a new robot promises to make the job easier and more accurate. Researchers at Rutgers University and Mount Sinai Hospital have developed a blood-sampling and testing device which uses ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
Automated blood drawing and testing
- 3rd MD Coronavirus Death, Medical Volunteers, Cases Near 200on March 21, 2020 at 4:08 pm
A Montgomery County woman is the state's 3rd coronavirus death. Gov. Hogan urges residents to give blood or volunteer at Maryland Responds.
- Blood Testing Market to Generate Huge Revenue during 2020 2025 | Abbott Laboratories, Quest Diagnostics, Danaheron March 19, 2020 at 3:43 am
This intelligence report provides a comprehensive analysis of the Global Blood Testing Market. This includes Investigation of past progress, ongoing market scenarios, and future prospects. Data True ...
- Antinuclear Antibody (ANA) Test Market 2020: Global Analysis, Industry Growth, Current Trends and Forecast till 2026on March 19, 2020 at 3:04 am
Wiseguyreports.Com Adds “Antinuclear Antibody (ANA) Test – Market Demand, Growth, Opportunities, Manufacturers and Analysis of Top Key Players to 2026” To Its Research Database. An antinuclear ...
- Todos Medical and 3DMed Enter Into Coronavirus (COVID-19) and Influenza A/B Testing Kit Distribution Agreement in US and Israelon March 17, 2020 at 10:07 am
3DMed test demonstrated 99.3% sensitivity and 100% specificity in Chinese clinical trial Nucleic Acid test performed on proprietary automated ...
- Now a robot that uses AI, imaging to draw blood, administer medicationson March 4, 2020 at 4:22 pm
In other published work, the authors have shown that the device can serve as a platform to merge automated ... to draw blood in rodents, a procedure which is extremely important for drug testing ...